Recent evidence from animal and human studies shows a role for the endocannabinoid system in maintaining energy balance and glucose as well as lipoprotein metabolism, according to a 2009 study. Modulation of this system has resulted in an improvement in a number of important risk factors in clinical trials, including visceral and subcutaneous abdominal adipose tissue, glucose tolerance, dyslipidemia and measures of inflammation.
You’ve most likely heard of CBD. It is becoming an increasingly popular choice for an array of health complaints and conditions. It is one of 104 cannabinoids, which are specific chemical compounds found in the Cannabis sativa plant. Unlike its sister cannabinoid, THC, CBD provides all the benefits of Cannabis without the psychoactive effects. In other words, it won’t make you high. While many full-spectrum CBD oils contain trace amounts of THC, the amount is negligible and has no noticeable effects.
Another marker of obesity and diabetes includes damage to liver cells. The liver is a major organ in the conversion between stored energy forms and useable energy forms in the body. Overburdening that system, such as with high fructose intake, can have disastrous effects. Inflammation within the liver indicates the onset of dysfunction, and possibly non-alcoholic fatty liver disease.